08208984 is referenced by 10 patents and cites 195 patents.

An apparatus comprises receiving a user prompt in a blood glucose (BG) management device to start a determination of an effective correction factor, receiving sampled blood glucose data of a patient obtained during a specified time duration, including a time duration after delivery of an initial insulin correction bolus, determining the effective correction factor using the BG management device according to a determined decrease in the blood glucose level of the patient and an amount of insulin in the initial insulin correction bolus, and cancelling the determination of the effective correction factor if a blood glucose level of the patient is outside of a specified range of blood glucose levels.

Title
Correction factor testing using frequent blood glucose input
Application Number
12/720306
Publication Number
8208984 (B2)
Application Date
March 9, 2010
Publication Date
June 26, 2012
Inventor
Rhall E Pope
Minneapolis
MN, US
Michael Blomquist
Blaine
MN, US
Agent
Patterson Thuente Christensen Pedersen P A
Assignee
Smiths Medical ASD
MA, US
IPC
A61B 5/00
View Original Source